- Home
- GROY vs PYXS Comparison
GROY vs PYXS Comparison
Compare GROY & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROY
- PYXS
- Stock Information
- Founded
- GROY 2020
- PYXS 2018
- Country
- GROY Canada
- PYXS United States
- Employees
- GROY N/A
- PYXS N/A
- Industry
- GROY
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- GROY
- PYXS Health Care
- Exchange
- GROY Nasdaq
- PYXS Nasdaq
- Market Cap
- GROY 231.6M
- PYXS 210.4M
- IPO Year
- GROY 2021
- PYXS 2021
- Fundamental
- Price
- GROY $1.31
- PYXS $2.10
- Analyst Decision
- GROY Strong Buy
- PYXS Strong Buy
- Analyst Count
- GROY 3
- PYXS 7
- Target Price
- GROY $3.58
- PYXS $9.57
- AVG Volume (30 Days)
- GROY 767.5K
- PYXS 1.5M
- Earning Date
- GROY 11-04-2024
- PYXS 11-12-2024
- Dividend Yield
- GROY N/A
- PYXS N/A
- EPS Growth
- GROY N/A
- PYXS N/A
- EPS
- GROY N/A
- PYXS N/A
- Revenue
- GROY $7,764,000.00
- PYXS $16,146,000.00
- Revenue This Year
- GROY $289.17
- PYXS N/A
- Revenue Next Year
- GROY $102.86
- PYXS N/A
- P/E Ratio
- GROY N/A
- PYXS N/A
- Revenue Growth
- GROY 197.02
- PYXS N/A
- 52 Week Low
- GROY $1.17
- PYXS $1.35
- 52 Week High
- GROY $2.21
- PYXS $6.85
- Technical
- Relative Strength Index (RSI)
- GROY 41.46
- PYXS 24.53
- Support Level
- GROY $1.27
- PYXS $3.88
- Resistance Level
- GROY $1.35
- PYXS $4.31
- Average True Range (ATR)
- GROY 0.05
- PYXS 0.36
- MACD
- GROY -0.01
- PYXS -0.17
- Stochastic Oscillator
- GROY 18.42
- PYXS 4.01
About GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and streaming company. It offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.